Navigation Links
Salient Mobility Launches the 'Text For a Cause(TM)' Campaign in Raising Awareness Through Wireless Health Tips
Date:6/12/2009

ccessible nationwide.

About Salient Mobility

Salient Mobility is a wireless technology firm that provides full service mobile text messaging platforms, utilizing SMS (Short Message Service), and WAP (Wireless Application Protocol).

Salient Mobility develops customized advertising campaigns that engage customers in one-to-many interactive wireless experiences. As a result of Salient Mobility's success in delivering mobile content, more and more people are requesting the platforms.

We have developed strong partnerships with many major industry leaders to ensure our solutions are compatible, well-connected and secure. Salient Mobility is headquartered in Atlanta, GA.

For more information, visit www.salientmobility.com/cause.htm (800) 206-0499


'/>"/>
SOURCE Salient Mobility LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Salient Corporations Performance Management Solution Helps NY State Counties Identify Medicaid Fraud, Waste, and Abuse
2. Cooper Martin Unveils Innovative, Stylish Recovery Clothing for Those with Limited Mobility
3. Extra Pounds in Mid-Life Affect Later Mobility
4. Motorola Study Shows 80 Percent of Global Healthcare IT Executives Placing Increased Reliance on Mobility
5. Universal Health Services, Inc. Enters Into Long-Term Agreement With Opus Healthcare Solutions for OpusMobility(R) and Support Services
6. Veteran Rehab Specialist, James Conwell, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania
7. Rehab Specialist, Michael Fisher, Joins Fast - Growing Alliance Seating & Mobility in North Carolina
8. Nurse & Veteran Rehab Specialist, Terri Witten, Joins Fast-Growing Alliance Seating & Mobility in Ohio
9. Veteran Rehab Specialist, Donna Cole, Joins Fast-Growing Alliance Seating & Mobility in California
10. Veteran Rehab Specialist, David Glancy, Joins Fast-Growing Alliance Seating & Mobility in Michigan
11. Drug Improves Mobility in Some MS Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNew...90s to eliminate onchocerciasis (river blindness) ...alence of the disease in recent years, as evidence...equiring mass drug administration in six endemic c... annual meeting of the American Society of Tropica...
(Date:11/21/2009)... HAPPYneuron,s most popul...e on the iPhone and iPod Touch. , ...09 -- HAPPYneuron,s most popular and addictive gam...iPod Touch. Split Words is designed to help banish...he SplitWords iPhone brain game challenges the b...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Fir...today that a Special Meeting of Shareholders will ...of the Meeting is to consider approval of two spec...o approve and authorize the sale of all or substan... on the terms provided for in the asset purchase a...
(Date:11/20/2009)..., , MADISON, N.J., Nov. 20 /PRNewswire-F...nfluenza virus may have peaked in late October, bu...al source of illness in all age groups, including ...agnostics Incorporated (NYSE: DGX ), the world,s...on and services. ,, In its most recent Quest D...
(Date:11/20/2009)..., , LAS VEGAS, Nov. 20 /PRNewswire-USNewswir...y, Executive Director of the Nevada Health Care As...on (NHCA) commends and thanks Senate Majority Lead...ion a step closer toward our goal of protecting ev...ing home care, and preserving the strength and via...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...n in people with diabetes than in those without th...sue of Archives of Ophthalmology , one of the JA...ion Americans had diagnosed diabetes mellitus in 2...ls with diagnosed diabetes will increase to 48.3 m...
... ,can,t remember anything, study says , , ...k may do more than help guide your daily sleep/wak...ng and memory, say Stanford University researchers...ut it, they "can,t remember anything," said lead a...
... on October 30 - - Presentation at Oppenheimer,s ... November 4 -, - Annual Analyst Day...s on November 7 -, S...Probe will release its third quarter 2008 financia...
...nal study Study needed because of low cardia...Advanced Circulatory Systems,Inc. ( http://www.adv...,received an additional $1.5 million in funding fr...a hospital. Oshkosh is one,of six sites included i...
...t Rights Management System, Supports Global Pharm...d, WEST CHESTER, Pa., Oct. 13 Modevity, LLC anno...anufacturer has integrated,Modevity,s Imperium tec...eo content. Imperium is applied to this,new medica...
...RT WORTH, Texas, Oct. 13 The Dannon Company, Inc.... the Will Rogers Memorial,Center. The company, whi...,out thousands of bottles of free Dannon smoothies...s about their food choices,to ensure a healthy fut...
Other Medicine News:Health News:Vision loss more common in people with diabetes 2Health News:Circadian Rhythm Plays Role in Memory 2Health News:Gen-Probe Announces Webcasts of Three Upcoming Investor Events 2Health News:Gen-Probe Announces Webcasts of Three Upcoming Investor Events 3Health News:Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:The Dannon Company Sponsors FitFuture KIDS Fest 2Health News:The Dannon Company Sponsors FitFuture KIDS Fest 3
(Date:11/19/2009)...ARK, Ill., Nov. 19 The ... as one of its Most Admired Corporate Dealmakers f...d Abbott as its Most Admired Dealmaker in pharma/b...uisitions and divestitures since January 2006. ,...usiness portfolio with a focus on high-growth, inn...
(Date:11/19/2009)...of International Internet Week of Action ,, SI...-- The U.S. Food and Drug Administration today com...rt, called the International Internet Week of Acti...ing medical products. ,, (Logo: http://www.new...ing the effort, the FDA,s Office of Criminal Inves...
(Date:11/19/2009)...ON, N.J., Nov. 19 Impliant, Inc., ...o traditional spinal fusion surgery, announced tod...anagement team as the Vice President of Clinical a...w.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO ...regulatory experience in the spinal and medical de...
Breaking Medicine Technology:The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Mobile MedCheck Brings Back House Calls 54959 1Mobile MedCheck Brings Back House Calls 54959 2Mobile MedCheck Brings Back House Calls 54959 3Mobile MedCheck Brings Back House Calls 54959 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3
...ree Oritavancin Studies Presented at ECCMID/ICC, M...ganta,Therapeutics today announced results from tw...cin to stop bacterial growth in vitro,when tested ...ne,study demonstrating the activity of oritavancin...ia. Oritavancin, a novel,lipoglycopeptide antibiot...
...istorical Analyses Help Plan for Future Pandemics ...tent riddles of the,deadly 1918 Spanish influenza ...rying severity. Why were some municipalities such ...s like Philadelphia,when both implemented similar ...according to two independent studies funded by the...
Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Rapid Response was Crucial to Containing the 1918 Flu Pandemic 2Rapid Response was Crucial to Containing the 1918 Flu Pandemic 3Rapid Response was Crucial to Containing the 1918 Flu Pandemic 4Rapid Response was Crucial to Containing the 1918 Flu Pandemic 5
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: